World's Best Scientists 2026 revealed!
Paul-Henri Lambert

Paul-Henri Lambert

D-Index & Metrics

Immunology

D-Index
85
Citations
24253
World Ranking
1326
National Ranking
33

Medicine

D-Index
85
Citations
24246
World Ranking
14692
National Ranking
211

Paul-Henri Lambert publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul-Henri Lambert sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 371 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul-Henri Lambert D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul-Henri Lambert sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul-Henri Lambert is affiliated with the University of Geneva in Switzerland and specializes in the field of Medicine. Their research spans multiple subfields, including Infectious Diseases, Epidemiology, Immunology, Health, and Molecular Biology.

Their recent scholarly output consists of research articles primarily published in prominent journals such as Vaccine, npj Vaccines, Frontiers in Immunology, Vaccines, and the International Journal of Molecular Sciences. Notable papers include:

  • Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) in npj Vaccines
  • Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine (2023) in Vaccines
  • Advanced vaccinology education: Landscaping its growth and global footprint (2020) in Vaccine
  • Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus (2021) in Vaccine
  • Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis (2022) in International Journal of Molecular Sciences

The research topics addressed in these works reflect a focus on vaccine development, immune cell function, and response mechanisms, as well as infectious disease epidemiology. Major thematic areas of their research include:

  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • Respiratory Viral Infections Research
  • Immune Cell Function and Interaction
  • Vaccines and Immunoinformatics Approaches
  • COVID-19 Clinical Research Studies
  • Viral Infections and Outbreaks Research

Collaboration has been a significant aspect of Paul-Henri Lambert's academic activity, with frequent coauthors including Claire-Anne Siegrist, Angela Huttner, David Pejoski, Paola Martinez-Murillo, and Francesco Santoro.

In addition to journal articles, Lambert has contributed to book publications, including a title with Frontiers Media: Le coronavirus et ces microbes qu'il nous faut combattre, première édition (2022).

The work of Paul-Henri Lambert contributes to ongoing research efforts in vaccine science, immune responses to infectious agents, and public health challenges related to viral epidemics and pandemics.

Best Publications

  • Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria

    Georges E. Grau;Terrie E. Taylor;Malcolm E. Molyneux;Jack J. Wirima

  • Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.

    Georges E. Grau;Luis F. Fajardo;Pierre-François Piguet;Bernard Allet

  • Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

    Eric Girardin;Georges E. Grau;Jean-Michel Dayer;Pascale Roux-Lombard

  • Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock

    Thierry Calandra;Jean-Daniel Baumgartner;Georges E. Grau;Mei-Miau Wu

  • Allergen immunotherapy: therapeutic vaccines for allergic diseases

    J. Bousquet;R. Lockey;H.J. Malling;E. Alvarez-Cuesta

  • APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

    Elodie Belnoue;Maria Pihlgren;Tracy L. McGaha;Chantal Tougne

  • Vaccination and autoimmune disease: what is the evidence?

    David C Wraith;Michel Goldman;Paul-Henri Lambert

  • In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus.

    Shozo Izui;Paul Henri Lambert;P. A. Miescher

  • Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

    Georges E. Grau;Hubertine Heremans;Pierre-Francois Piguet;Pascal Pointaire

  • Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

    Paul Henri Lambert;Philippe E. Laurent

  • New vaccines for tuberculosis

    Stefan H. E. Kaufmann;Gregory Hussey;Paul-Henri Lambert

  • Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2‐biased pattern which persists after adult boosting

    Christy Barrios;Pierre Brawand;Monika Berney;Christian Brandt

  • Tumor-Necrosis Factor and other Cytokines in Cerebral Malaria: Experimental and Clinical Data

    Georges E. Grau;Pierre-FranClois Piguet;Pierre Vassalli;Paul-Henri Lambert

  • Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

    R H Zubler;U Nydegger;L H Perrin;k Fehr

  • Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

    L H Perrin;P H Lambert;P A Miescher

  • Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination

    Martin O. C. Ota;Johan Vekemans;Susanna E. Schlegel-Haueter;Katherine Fielding

  • Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime‐boost strategies in mice

    Claire-Anne Siegrist;Christy Barrios;Xavier Martinez;Christian Brandt

  • CpG Oligodeoxynucleotides Can Circumvent the Th2 Polarization of Neonatal Responses to Vaccines But May Fail to Fully Redirect Th2 Responses Established by Neonatal Priming

    Jiri Kovarik;Paola Bozzotti;Laurie Love-Homan;Maria Pihlgren

  • Can successful vaccines teach us how to induce efficient protective immune responses

    Paul Henri Lambert;Margaret Liu;Claire-Anne Siegrist

  • Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled C1q binding and Raji-cell RIA tests

    P. Casali;A. Bossus;Nicole A. Carpentier;P.-H. Lambert

Frequent Co-Authors

Claire-Anne Siegrist
Claire-Anne Siegrist University of Geneva
Shozo Izui
Shozo Izui University of Geneva
Rafael A. García
Rafael A. García University of Paris-Saclay
Georges E. Grau
Georges E. Grau University of Sydney
Michel Goldman
Michel Goldman Université Libre de Bruxelles
Jacques A. Louis
Jacques A. Louis Institut Pasteur
Daniel D. Pinschewer
Daniel D. Pinschewer University of Basel
Giuseppe Del Giudice
Giuseppe Del Giudice GlaxoSmithKline (United Kingdom)
Pierre Vassalli
Pierre Vassalli University of Geneva
Peter E. Andersen
Peter E. Andersen Technical University of Denmark

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Programs like the cheapest pmhnp programs online offer an affordable path into psychiatric nursing, which often intersects with immunological research in mental health contexts.

Understanding salary trends is also crucial when choosing a specialization. According to recent data, some of the highest paid dnp specialties align with acute care and advanced practice nursing roles, providing financial incentives alongside professional growth.

For nurses aiming to shift their focus, obtaining an acute care nurse practitioner certification can open doors to critical care environments where immunological expertise is highly valued.

Additionally, accelerated programs such as accelerated fnp programs enable quicker transitions into family nurse practitioner roles, allowing professionals to integrate immunological knowledge in primary care settings efficiently.

Best Scientists Citing Paul-Henri Lambert

Trending Scientists

Recently Published Articles